Alzheimer's disease brain-derived extracellular vesicles reveal altered synapse-related proteome and induce cognitive impairment in mice
- PMID: 37204850
- DOI: 10.1002/alz.13134
Alzheimer's disease brain-derived extracellular vesicles reveal altered synapse-related proteome and induce cognitive impairment in mice
Abstract
Introduction: Extracellular vesicles (EVs) have been implicated in the spread of neuropathology in Alzheimer's disease (AD), but their involvement in behavioral outcomes linked to AD remains to be determined.
Methods: EVs isolated from post mortem brain tissue from control, AD, or frontotemporal dementia (FTD) donors, as well as from APP/PS1 mice, were injected into the hippocampi of wild-type (WT) or a humanized Tau mouse model (hTau/mTauKO). Memory tests were carried out. Differentially expressed proteins in EVs were assessed by proteomics.
Results: Both AD-EVs and APP/PS1-EVs trigger memory impairment in WT mice. We further demonstrate that AD-EVs and FTD-EVs carry Tau protein, present altered protein composition associated with synapse regulation and transmission, and trigger memory impairment in hTau/mTauKO mice.
Discussion: Results demonstrate that AD-EVs and FTD-EVs have negative impacts on memory in mice and suggest that, in addition to spreading pathology, EVs may contribute to memory impairment in AD and FTD.
Highlights: Aβ was detected in EVs from post mortem AD brain tissue and APP/PS1 mice. Tau was enriched in EVs from post mortem AD, PSP and FTD brain tissue. AD-derived EVs and APP/PS1-EVs induce cognitive impairment in wild-type (WT) mice. AD- and FTD-derived EVs induce cognitive impairment in humanized Tau mice. Proteomics findings associate EVs with synapse dysregulation in tauopathies.
Keywords: Alzheimer's disease; brain-derived EVs; extracellular vesicles; proteomics; tauopathies.
© 2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
References
REFERENCES
-
- Ferreira ST, Klein WL. The Abeta oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease. Neurobiol Learn Mem. 2011;96(4):529-543. doi:10.1016/j.nlm.2011.08.003
-
- Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984;120(3):885-890
-
- Ballatore C, Lee VM, Trojanowski JQ. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci. 2007;8(9):663-672. doi:10.1038/nrn2194
-
- Rajendran L, Honsho M, Zahn TR, et al. Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A. 2006;103(30):11172-11177. doi:10.1073/pnas.0603838103
-
- Rajendran L, Knobloch M, Geiger KD, et al. Increased Abeta production leads to intracellular accumulation of Abeta in flotillin-1-positive endosomes. Neurodegener Dis. 2007;4(2-3):164-170. doi:10.1159/000101841
Publication types
MeSH terms
Substances
Grants and funding
- P30 AG066511/AG/NIA NIH HHS/United States
- K24 AG053435/AG/NIA NIH HHS/United States
- F32 AG074625/AG/NIA NIH HHS/United States
- T32 GM139780/GM/NIGMS NIH HHS/United States
- R01 AG060477/AG/NIA NIH HHS/United States
- P30 AG062422/AG/NIA NIH HHS/United States
- R21 AG074220/AG/NIA NIH HHS/United States
- R01 AG060731/AG/NIA NIH HHS/United States
- R01 AG025340/AG/NIA NIH HHS/United States
- R01 AG062581/AG/NIA NIH HHS/United States
- K23 AG058805/AG/NIA NIH HHS/United States
- R01 AG070826/AG/NIA NIH HHS/United States
- P01 AG014449/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous